Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of the Cholinesterase Inhibitor Donepezil on Organic and Functional Deficits Associated With Age-Related Decrease of Growth Hormone

NCT00533065 is registered in ClinicalTrials.gov with Ludwig Boltzmann Gesellschaft as lead sponsor.

NCT NCT00533065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00533065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of the Cholinesterase Inhibitor Donepezil on Organic and Functional Deficits Associated With Age-Related Decrease of Growth Hormone
Lead sponsor
Ludwig Boltzmann Gesellschaft
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2007
Completion date
July 31, 2009
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elderly